2014
DOI: 10.1016/j.clinthera.2014.05.010
|View full text |Cite
|
Sign up to set email alerts
|

Expression of B-Cell Surface Antigens in Subpopulations of Exosomes Released From B-Cell Lymphoma Cells

Abstract: Distribution of exosomes that contain CD19, CD20, CD24, CD37, and HLA-DR may intercept immunotherapy directed against these antigens, which is important to be aware of for optimal treatment. The use of an immunomagnetic separation platform enables easy isolation and characterization of exosome subpopulations for further studies of the exosome biology to understand the potential for therapeutic and diagnostic use.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

13
90
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 138 publications
(116 citation statements)
references
References 54 publications
13
90
0
Order By: Relevance
“…Some groups have recently performed comparative proteomic analyses of medium-sized and small EVs (with or without floatation into a gradient) from platelets (19) or tumor cells (26)(27)(28)(29). Another group has compared the expression of a few surface proteins on B lymphoma-EVs immunoprecipitated with either CD9, CD63, or CD81 (30). Our results are consistent with these other recent works, especially in identifying sEV-enriched proteins (e.g., TSG101 and CD81).…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…Some groups have recently performed comparative proteomic analyses of medium-sized and small EVs (with or without floatation into a gradient) from platelets (19) or tumor cells (26)(27)(28)(29). Another group has compared the expression of a few surface proteins on B lymphoma-EVs immunoprecipitated with either CD9, CD63, or CD81 (30). Our results are consistent with these other recent works, especially in identifying sEV-enriched proteins (e.g., TSG101 and CD81).…”
Section: Discussionsupporting
confidence: 90%
“…Some cell types, however, secrete sEVs devoid of CD63 (30,33,34), and for these it will be necessary to analyze instead either CD81-or CD9-bearing sEVs. In addition, given its presence in large EVs, CD63 cannot be used as specific exosome-isolation tool without a first step of elimination of these large EVs.…”
Section: Discussionmentioning
confidence: 99%
“…Size-based separation cannot distinguish among subpopulations of EVs. For example, if the goal is to distinguish the CD81+ subpopulation of EVs from the CD63+ subpopulation, immunoaffinity is recommended [64]. Many studies have discovered EV biogenesis and subpopulations by exploiting the interaction of surface proteins with specific antibodies.…”
Section: Immunoaffinitymentioning
confidence: 99%
“…Because bulk assays analyze an ensemble of EV, bulk assays are generally more sensitive and faster than single EV techniques. A typical disadvantage of bulk assays is that information on the EV concentration, biochemical heterogeneity, and polydispersity is lost [1,2]. We will limit the scope of this review by exclusion of proteomics, lipidomics, nucleotide sequencing assays, and polymerase chain reaction [3][4][5][6][7][8], enabling us to focus on bulk immunoassays (BIA).…”
Section: Introductionmentioning
confidence: 99%